Navigation Links
Type 2 Diabetes Control Worsening, According To Study Of Patients On Commercial Insurance
Date:5/22/2013

results to differ materially from those described or projected herein include the following: uncertainties associated generally with research and development, clinical trials and related regulatory reviews and approvals. The forward looking statements contained herein are made only as of the date of this press release and Valeritas undertakes no obligation to update or revise the information contained in this press release, whether as a result of new information, future events or circumstances or otherwise.

References

1. Rosenfeld, C., and Grunberger, G. Effectiveness of V-Go for Patients with Diabetes in a Real-World Setting: A Long-Term, Prospective, Observational Registry (SIMPLE). Date to be presented at the American Association of Clinical Endocrinologists Annual Meeting. May 1 – 5, 2013. Phoenix, Arizona. 2. American Diabetes Association, Diabetes Basics. http://www.diabetes.org/diabetes-basics/diabetes-statistics/?loc=DropDownDB. Published 2012. Accessed November 5, 2012.
3. National Diabetes Information ClearingHouse. National Diabetes Statistics. 2011. http://diabetes.niddk.nih.gov/dm/pubs/statistics/#fast. Accessed November 5, 2012.


'/>"/>
SOURCE Valeritas, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Elcelyx Therapeutics Enrolling Phase 2b Trial of NewMet for Type 2 Diabetes
2. Neuralstem ALS Trial Principal Investigator, Dr. Eva Feldman, Presented Phase I Data At The Neuro Diabetes Medical Symposium In Romania
3. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
4. Merck and Celebrity Chef Art Smith "Cook Up a Recipe" for Better Type 2 Diabetes Management
5. Retrospective analysis of linagliptin data in sub-populations with type 2 diabetes presented at AACE 22nd Annual Scientific & Clinical Congress
6. New Interim Analysis From Observational Study Suggests That Delivery Of Insulin Via Valeritas V-Go Shows Promise In Improving Glycemic Control For Patients With Type 2 Diabetes
7. Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes
8. Abide Therapeutics Announces Collaboration With Merck to Develop Novel Therapies for Type 2 Diabetes and Metabolic Diseases
9. Judge Nullifies Verdict in Diabetes Drug Case
10. The Importance of Emergency Preparedness: Lilly Diabetes and the American College of Endocrinology (ACE) Help Prep People with Diabetes for Emergencies - Big or Small
11. Clinical Results for Orameds Oral Diabetes Treatment Published in Peer Reviewed Journal PLOS ONE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/30/2015)... ISELIN, N.J. , March 30, 2015 /PRNewswire/ ... a medical device company focused on non-invasive continuous ... it has achieved its wireless mobile communication milestone, ... sensor to transmit data to any mobile platform. ... the strategic transformation of the Company,s technology from ...
(Date:3/30/2015)... -- RnRMarketResearch.com adds "CountryFocus: Healthcare, Regulatory and ... research report of 295 pages with latest updates, data ... The report " CountryFocus: Healthcare, Regulatory and Reimbursement ... and analysis of the healthcare, regulatory and reimbursement landscape ... key trends in the country,s healthcare market, and provides ...
(Date:3/30/2015)... 2015  IRIDEX Corporation (Nasdaq: IRIX ) today ... granted the Company a patent for a new proprietary ... eye surgery. The iClip Closure Device will initially be ... a broader range of ophthalmic surgical procedures in the ... procedure used in the treatment of glaucoma to drain ...
Breaking Medicine Technology:Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone 2Echo Therapeutics, Inc. Achieves Wireless Mobile Communication Milestone 3Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 2Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 3Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 4Spain Medical Devices Market Worth $12 Billion With 4.5% CAGR to 2020, Says RnRMarketResearch.com 5IRIDEX Granted U.S. Patent for Disposable Device for Efficient and Predictable Wound Closure in Eye Surgeries 2
... 19, 2011 Enhanced Equity Fund (EEF), a healthcare-focused ... investment in MedTest DX, Inc. (MedTest), a medical diagnostic ... to purchase the chemistry diagnostics business from Polymedco, Inc. ... of EEF.  Terms were not disclosed. "EEF ...
... 2011 Wound Management Technologies, Inc., (OTCQB: WNDM | ... the publication of an interview of its President Deborah ... of interviews with CEOs and CFOs of publicly traded ... conducted by Lynn Fosse, Senior Editor, CEOCFOInterviews.com include why ...
Cached Medicine Technology:Enhanced Equity Fund and James White Invest in MedTest DX, Inc. 2WNDM President Interviewed; Discusses 2011 Outlook and Beyond 2WNDM President Interviewed; Discusses 2011 Outlook and Beyond 3
(Date:3/30/2015)... Daily sun exposure, stressors and environmental ... wrinkles, folds and other giveaways of age. However, advances ... women to hit the pause button, delaying the impact ... tuck or hack to rejuvenate any facial feature. , ... Surgery (AAFPRS) explores the intricacies of The Aging ...
(Date:3/30/2015)... Considered to be the best assessment tool for ... community, this next generation of the IT Audit ... data and frameworks with virtually endless possibilities. These new ... logic features are a technological force to be reckoned ... “The IT Audit Machine is just one of the ...
(Date:3/30/2015)... March 30, 2015 Cutting-edge doctors and ... 2015 Conference because of the opportunities to present and ... conference will highlight parents of recovered children, who will ... Romaniec, will debut her book Victory over Autism: Practical ... Free copies of Victory over Autism will be available ...
(Date:3/30/2015)... (PRWEB) March 30, 2015 Developing new ... to the use of cellular models that recapitulate only ... entirety of the disease. , A company that ... cells to precise specifications has created iPSC-derived cardiomyocytes ... environmentally and genetically driven in vitro models of Diabetes ...
(Date:3/29/2015)... At the 2015 International Health Racquet & ... the new Fonda wall mounted heater and a continuing ... and facilities managers with saunas smaller than 425 cubic ... the Fonda heater. With an attractive seamless red ... upgrade for a sauna, especially when mounted in front ...
Breaking Medicine News(10 mins):Health News:New AAFPRS Infographic Addresses Concerns and Provides Aging Face Solutions 2Health News:Building on Success: Next Generation of Cyber Crime Prevention Unveiled! 2Health News:AutismOne and Focus for Health Highlight Victory over Autism at Major Chicago Conference Following Autism Awareness Month 2Health News:AutismOne and Focus for Health Highlight Victory over Autism at Major Chicago Conference Following Autism Awareness Month 3Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 2Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 3Health News:Cellular Dynamics’ Webinar Spotlights Diabetic Cardiomyopathy-in-a-dish Model that May Elucidate Mechanisms for Repair and Regeneration of Heart Muscle Cells 4Health News:Helo Commercial Introduces Fonda Sauna Heater and Sauna and Steam Continuing Education Program at IHRSA 2
... Sweden have successfully transferred a uterus into a sheep, and ... They explained that the operation proves that a womb can ... an animal. ,Tests that were conducted on the ... surgery and is continuing to function normally. It was explained ...
... been found to have a role in the treatment of ... // ,The results of the study have been ... Journal of Medicine, which has revealed that this immunosuppressive drug ... as well as the quality of life for people with ...
... forensic medicine lecturer faces disbarment from Medical Council of India (MCI) ... the same time, which is against the rules of the MCI. ... his employment with Sion Hospital. ,If he is debarred, ... has already been debarred till July 31, 2007 for an earlier ...
... to buy Swedish medical company Biacore to complement its ... announced. // ,The Fairfield, Connecticut-based GE will ... for 3.22 billion Swedish kroner ($438 million). ... percent stake in Uppsala, Sweden-based Biacore, supports the bid, ...
... to thee?' - sounds odd?,But it is a dyslexic's mode ... , The learning disability, dyslexia, has a genetic component, ... opens up ways for treatment. , Dyslexia ... Network report that they have located the dyslexia gene, denoted ...
... insisted that hospital consultants who are not referring patients to ... concerns that the NTPF has only seen a fraction of ... ,NTPF chairman Pat O'Byrne commented that there was no ... months for a surgical procedure. ,"There's no doubt ...
Cached Medicine News:Health News:Scientists Claim Human Womb Transplants Possible 2Health News:Cancer Drug to Treat Scleroderma Lung Disease 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: